Omzet 2024 * | 55,18 mld. 50,84 mld. | Omzet 2025 * | 58,07 mld. 53,5 mld. | Marktkapitalisatie | 274 mld. 253 mld. |
---|---|---|---|---|---|
Nettowinst (verlies) 2024 * | 7,74 mld. 7,13 mld. | Nettowinst (verlies) 2025 * | 10,56 mld. 9,72 mld. | EV/omzet 2024 * | 5,96 x |
Nettoschuld 2024 * | 54,72 mld. 50,41 mld. | Nettoschuld 2025 * | 47,3 mld. 43,58 mld. | EV/omzet 2025 * | 5,54 x |
K/w-verhouding 2024 * |
30,2
x | K/w-verhouding 2025 * |
23,2
x | Werknemers | - |
Dividendrendement 2024 * |
3,99% | Dividendrendement 2025 * |
4,19% | Vrij verhandelbaar | 96,38% |
Recentste transcriptie over AbbVie
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Richard Gonzalez
CEO | Chief Executive Officer | 70 | 01-01-13 |
Scott Reents
DFI | Director of Finance/CFO | 57 | 01-01-13 |
Robert Michael
PSD | President | 53 | 01-01-12 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Roxanne Austin
BRD | Director/Board Member | 63 | 01-01-13 |
Edward Rapp
BRD | Director/Board Member | 66 | 01-01-13 |
Director/Board Member | 70 | 01-01-13 |
Vaira. 1 jan. | Kapi. | |
---|---|---|
+38,59% | 727 mld. | |
-7,89% | 347 mld. | |
+15,66% | 319 mld. | |
+13,75% | 238 mld. | |
+6,83% | 204 mld. | |
-6,54% | 203 mld. | |
+4,23% | 161 mld. | |
-1,70% | 160 mld. | |
-1,41% | 120 mld. |